Tamarin Headshot2
Tamarin Lindenberg, CEO

Tamarin has an extensive track record in transitional management with experience in accelerated/focused growth, realignment, and innovative market positioning. She has served a variety of clients in each sector of the healthcare industry, and is the founder and creator of CALIEB, a Patient Advocacy Program for women facing female and breast cancer.

Highly regarded as a results oriented leader with strong interpersonal skills, Tamarin has the ability to create, evaluate, analyze, and implement defined plans and objectives to achieve organizational goals. Recognized for an ability to balance strategy and execution, her expertise includes the full range of business life cycles.

Tamarin has participated in several research studies with leading investigators and has published articles in a variety of periodicals. She served as Principal Investigator on a four-year research study designed to assess the cultural readiness for change necessary for economic development in emerging and secondary markets.

She has authored a number of white papers, including “Integrating Business Management Tools into the Clinical Research Environment,” “The Business of Biotechnology,” “The Art of Collaboration,” and “A Woman’s Influence in Family Health.” A member of Women Business Leaders in Healthcare, a DC based invitation-only group of top healthcare professionals, Tamarin has also served on a panel of experts for NYC’s WUI, as a mentor for the WUI LEAD program, which provides business insight to Fortune 500 “high potentials” in management. She served as an advisor to Asian Pacific Executive MBA students at Boston University’s School of Management.

Tamarin holds a Master of Management with a dual concentration in Organization Development and Business Negotiations and Conflict Resolution from Cambridge College in Boston, Massachusetts. She was awarded a partial fellowship for the Case Western Reserve University Doctorate Of Management program for her work in cultural competency.
The Senior Team